BioNTech SE Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	141,929	168,961	121,737	192,994	346,917	101,936
Market Cap Growth	-8.27%	38.79%	-36.92%	-44.37%	240.33%	230.82%
Enterprise Value	55,945	55,379	41,890	124,802	333,306	96,785
Last Close Price	35.16	44.00	31.80	50.38	-	-
PE Ratio	-	-	24.40	3.62	5.32	1055.70
PS Ratio	7.20	9.59	5.94	1.97	2.89	33.27
PB Ratio	1.23	1.36	1.12	1.70	4.60	11.70
P/TBV Ratio	1.36	1.45	1.19	1.72	4.68	13.22
P/FCF Ratio	-	-	4.43	2.58	71.83	-
P/OCF Ratio	-	127.04	4.23	2.52	61.54	-
EV/Sales Ratio	2.95	3.14	2.05	1.28	2.77	31.59
EV/EBITDA Ratio	-	-	7.04	1.84	3.53	-
EV/EBIT Ratio	-	-	8.04	1.85	3.54	-
EV/FCF Ratio	-18.06	-	1.53	1.67	69.01	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.03	0.18
Debt / EBITDA Ratio	-	-	0.19	0.02	0.02	-
Debt / FCF Ratio	-	-	0.04	0.02	0.40	-
Net Debt / Equity Ratio	-0.77	-0.85	-0.81	-0.69	-0.15	-0.81
Net Debt / EBITDA Ratio	30.53	16.00	-14.71	-1.16	-0.12	3.83
Net Debt / FCF Ratio	28.84	209.76	-3.19	-1.05	-2.33	13.93
Asset Turnover	0.14	0.12	0.17	0.89	2.09	0.31
Inventory Turnover	2.09	1.69	1.51	6.36	10.28	1.56
Quick Ratio	6.89	7.26	9.12	7.19	4.15	2.50
Current Ratio	7.12	7.45	9.43	7.43	4.33	2.75
Return on Equity (ROE)	-3.04%	-3.36%	4.62%	59.06%	155.18%	1.63%
Return on Assets (ROA)	-2.30%	-3.53%	2.62%	38.09%	102.25%	-12.89%
Return on Invested Capital (ROIC)	-18.04%	-37.82%	15.07%	106.34%	195.58%	-206.44%
Return on Capital Employed (ROCE)	-4.20%	-6.40%	4.60%	58.60%	120.20%	-18.80%
Earnings Yield	-2.52%	-2.52%	4.10%	27.62%	18.80%	0.10%
FCF Yield	-2.18%	-0.30%	22.56%	38.78%	1.39%	-0.50%
Buyback Yield / Dilution	0.40%	0.95%	2.84%	3.81%	-4.51%	-17.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.